Drug recalls due to failed quality tests have seen a concerning rise in India, from 950 batches in 2019-20 to a provisional 1,394 in 2023-24. Over 2,900 drug samples failed quality checks this year, with 282 deemed spurious or adulterated, leading to over 600 prosecutions.
